IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Docmode Health Technologies IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Education - Edtech sector. Fedex Securities Private is the merchant banker of Docmode Health Technologies IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th April 2023.
Docmode Health Technologies IPO posted revenues of Rs 47.34 crores and PAT of Rs 2.72 crores in FY24 on annualised basis.Financial results of Docmode Health Technologies IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Docmode Health Technologies IPO PAT Margin is 5.75%, ROCE (Return on Capital Employed) is 19.83% as per latest financial. The below table shows Docmode Health Technologies IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Docmode Health Technologies IPO is Rs 24.83 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Docmode Health Technologies IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Docmode Health Technologies IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Docmode Health Technologies IPO is ₹24.83 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Docmode Health Technologies IPO has a Price-to-Earnings (PE) ratio of 9.13 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Docmode Health Technologies IPO reported revenue of ₹47.34 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Docmode Health Technologies IPO provide insights into sales growth, market demand, and business scalability.
Docmode Health Technologies recorded an EBITDA of ₹ 5.42 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Docmode Health Technologies Profit After Tax (PAT) is ₹2.72 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 47.34 Cr.
EBITDA Margin:
11.45
%
Net Worth: ₹ 4.84 Cr.
Market Capitalisation:
₹ 24.83 Cr.
P/E:
9.13 times
P/BV: 2.15 times
EV/EBITDA: 5.94 times
Docmode Health Technologies operates in Education - Edtech and Int Learning Solutions To Healthcare. The Issue is listed on NSE EMERGE in Feb, 2024. Docmode Health Technologies IPO size was 6.71 with Issue price of 79.00 .
Merchant Banker(s) of Docmode Health Technologies IPO: Fedex Securities Private Limited
Docmode Health Technologies IPO subscription was 215.24 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Docmode Health Technologies IPO listed at a listing price of 180.75 against the offer price of 79.00.
The current market price of Docmode Health Technologies is 50.45.
Why Us?
